MRI Contrast Agents Market Size, Trends and Insights By Modality (X-ray, CT scan, Ultrasound, MRI scan), By Product Type (Barium based, Iodinated, Micro-bubble, Gadolinium based), By Application (Neurological disorder, Cardiovascular disorder, Cancer, Gastrointestinal disorder, Musculoskeletal disorder, Nephrological disorder, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2022–2030


Report Code: CMI18482

Published Date: September 2022

Pages: 220+

Category: Healthcare

Reports Description

According to Custom Market Insights (CMI), The Global MRI Contrast Agents Market has presented a growth of USD 2.2 billion by 2021 to USD 2.08 billion in 2022 and is expected to touch USD 4.54 billion by the end of 2030 at a compound annual growth rate of 6.2% during the future.

The huge number of cases in the health care system that require imaging techniques to arrive at a suitable diagnosis which assists the physician in choosing a suitable line of treatment for the patient has helped the contrast agent for the MRI market to record a considerable revenue over the period. It is expected to continue similarly in the future because of the huge number of patients emerging in the present market.

MRI Contrast Agents Market Size

To learn more about this report, 

Various imaging techniques available in the healthcare system make use of a suitable contrast agent that provides maximum visualization, which helps arrive at a suitable diagnosis for the patient. The pandemic outbreak significantly impacted the MRI Contrast Agents market as various restrictions were imposed by the government and the healthcare sector regarding regular follow-ups and other associated treatments other than the pandemic.

Growth Factors

The huge number of patients suffering from chronic diseases worldwide has emerged as a major market for MRI Contrast Agents, which is expected to increase the number of people belonging to the geriatric population. The increasing demand for advanced healthcare facilities by the people owing to the increasing disposable income has helped the market record considerable revenue. Various lucrative offers provided to potential consumers by the government in reimbursement facilities have also helped the market record considerable revenue in this period.

The increasing demand for advanced healthcare systems among people after the outbreak of the pandemic has boosted the demand for better contrast agents, which help to devise an accurate diagnosis. The rapidly increasing number of patients suffering from pathological changes has also boosted the market for contrast agents to a great extent, as it requires imaging techniques to find out the exact problem with the patient.

MRI Contrast Agents Market (By Modality)

To learn more about this report, 

Segmental Insights

Segmentation of MRI Contrast Agents market based on modality 

Based on modality, the X-ray and CT scan segment has emerged as the largest market for the huge demand for these facilities among potential consumers worldwide. 3D images are produced with a very high resolution that helps to identify the underlying structures and provide the best possible diagnosis with the help of the reports.

The media utilized for such procedures is usually barium based, which helps to provide the best possible results after the conduction of the test. With the administration of iodine and barium contrast agents, the X-rays are blocked, which does not allow them to pass from the organs.

The ultrasound segment is expected to show faster growth owing to the huge demand for this procedure among potential consumers as it experiences a huge client base. The female population mainly forms the potential client base for the procedure of ultrasound which is seen as another reason for market growth in the future as well. Using several patients suffering from stomach disorders and pathological changes has boosted the demand for ultrasound methods that include the use of contrast agents for confirming the patient’s diagnosis, which will, in turn, assist the physician in choosing a suitable line of treatment for the patient.

Micro-bubbles act as an agent used in contrast for these procedures, which helps to make a detailed assessment of the patient’s condition. The pediatric patient is also found as a huge client base for the ultrasound procedure with ionizing radiation.

Segmentation of MRI Contrast Agents market based on Product Type

Based on product type, the segment of iodinated contrast media has emerged as the largest global market owing to the extensive use of this contrast media for various scanning procedures in the healthcare sector worldwide. The use of this particular media in the CT scan procedures and techniques has emerged as a major factor in boosting the economy for this particular segment under this category. The usage of non-ionic stable agents, which are iodinated, has helped to boost the quality of diagnosis, which has greater precision and accuracy and hence assists the physician in choosing a suitable line of treatment for the patient.

The intravenous route of administration is usually considered for the iodinated contrast media as it is the first choice, according to the healthcare sector. The use of barium-based contrast media has also been observed on a large scale in exchange for this media administered orally or through the rectum. The visualization process of the gastrointestinal tract and the other internal organs is enhanced tremendously with the use of this contrast media, which makes it possible to devise a suitable diagnosis of the patient.

MRI Contrast Agents Market (By Product Type)

To learn more about this report, 

A huge number of cases use this particular contrast media as it has a wide scope of Applications and diseases relating to the cardiovascular system, musculoskeletal disorders, nephrological system, gastrointestinal system, cancer and neurological system. The segment of micro-bubble contrast media is also foreseen to grow fast over the increasing number of scanning techniques that utilize this particular contrast media. The ultrasound imaging techniques for detecting pathological changes in the heart usually use this micro-bubble contrast media. It provides better visualization and assists in making a suitable diagnosis for the patient.

Segmentation of MRI Contrast Agents market based on Application

Based on Application, the segment of neurological disorders has emerged as the largest global market of the increased number of people that suffer from neurological disorders due to the increasing workload and stress experienced by the working and geriatric population.

The various scanning methods and imaging techniques used for diagnosing such cases related to neurological disorders have emerged as a major factor in the growth of the neurological disorder segment, which is expected to grow further in the future. New managing techniques provide a better study of the neurological system regarding the new plastic lesions, inflammatory conditions, demyelinated areas and other pathological disorders. For all these procedures, the most suitable contrast media is the gadolinium-based contrast agent.

One of every three MRI imaging techniques makes use of gadolinium-based contrast media, which helps to perform and conclude a suitable diagnosis that is highly accurate. The visibility provided with this gadolinium-based contrast media helps to have a clear vision regarding the inflammatory conditions, blood vessels and tumors formed within the body system.

The administration of the gadolinium contrast media is usually done through the intravascular system as it serves as the most suitable line of administration among the patients belonging to the pediatric age group, which is about two years. This media is usually used to have a better visual facility with a view to observe the various abnormalities in the vascular system of the brain, tissues and spine.

The segment of cardiovascular system has also emerged as one of the leading market segments owing to the huge number of patients who suffer from such disorders. Ultrasound imaging techniques, based on the use of contrast media, have emerged as the fastest growing market as it is considered the most effective method of diagnosis confirmation in the health care system.

Regional Insights

Based on geography, the region of North America has emerged as the largest global market pertaining to the huge number of diagnostic imaging techniques that are utilized in the healthcare sector, which make use of high-grade contrast media that helps to provide better visualization of the pathological changes that have taken place in the various systems of the body.

The existence of the key market players in this region has also emerged as a major growth factor for the contrast agents market of the constant research and development programs that they carry out to introduce new and advanced contrast media into the healthcare sector, which will help to provide better results with accuracy.

The highly developed healthcare facilities provided to the people by the government have boosted the demand for advanced imaging techniques that use contrast agents. The region of Asia Pacific has also emerged as one of the fastest-growing markets for contrast media due to the huge number of surgical procedures carried out in this region. Increasing demand for advanced health care facilities among the people and the increasing disposable income have led the contrast agents market to record considerable revenue over the period.

 MRI Contrast Agents Market (trends by region)

To learn more about this report, 

Report Scope

Feature of the Report Details
Market Size in 2021 USD 2.2 billion
Projected Market Size in 2030 USD 4.54 billion
CAGR Growth Rate 6.2 % CAGR
Base Year 2021
Forecast Period 2022-2030
Prominent Players GE Healthcare, Bracco Imaging SPA, Bayer AG, Guerbet, Lantheus Medical Imaging, Unijules Life Sciences, J.B. Chemicals and Pharmaceuticals Ltd., SANOCHEMIA Pharmazeutika GmbH, Taejoon Pharm, Jodas Expoim, Nano Therapeutics Pvt. Ltd., Kiran X-ray, iMax Diagnostic Imaging Limited, YZJ Group, Livealth Biopharma Pvt. Ltd., Trivitron Healthcare Pvt. Ltd., Novalek Pharmaceuticals Pvt. Ltd., Unispire Biopharma Private Limited, Acro Lifesciences (I) Pvt. Ltd., Congruent Pharmachem Private Limited, Stanex Drugs & Chemical Pvt. Ltd., Beijing Beilu Pharmaceutical Co. Ltd., Rege Imaging & Cine Films Private Limited, K DIAM EXIM, Subhra Pharma Pvt. Ltd. , and Others
Key Segment By Modality, Product Type, Application, and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfil your requirements for research.

Recent developments

  • In 2020 – GE Healthcare Pharma Ltd took over Daiichi Sankyo’s diagnostic agents as the owner in Japan.
  • In 2020 – Bracco Imaging SpA was granted permission through the US FDA for its ProHance product. It is used as an MRI contrast agent mainly for patients belonging to the pediatric age group below the age of two.
  • In 2019 – Bayer AG was granted permission by Gadavist, which is a gadolinium-based contrast agent. It is mainly utilized in cardiac MRI with a view to diagnosing coronary artery disease.
  • In 2019 – a collaboration took place between InterSystems Corporation and Guerbet with a view to expanding Guerbet’s solutions.

Key Players

  • GE Healthcare
  • Bracco Imaging SPA
  • Bayer AG
  • Guerbet
  • Lantheus Medical Imaging
  • Unijules Life Sciences
  • B. Chemicals and Pharmaceuticals Ltd.
  • SANOCHEMIA Pharmazeutika GmbH
  • Taejoon Pharm
  • Jodas Expoim
  • Nano Therapeutics Pvt. Ltd.
  • Kiran X-ray
  • iMax Diagnostic Imaging Limited
  • YZJ Group
  • Livealth Biopharma Pvt. Ltd.
  • Trivitron Healthcare Pvt. Ltd.
  • Novalek Pharmaceuticals Pvt. Ltd.
  • Unispire Biopharma Private Limited
  • Acro Lifesciences (I) Pvt. Ltd.
  • Congruent Pharmachem Private Limited
  • Stanex Drugs & Chemical Pvt. Ltd.
  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Rege Imaging & Cine Films Private Limited
  • K DIAM EXIM
  • Subhra Pharma Pvt. Ltd.

Segments covered in the report

By Modality

  • X-ray
  • CT scan
  • Ultrasound
  • MRI scan

By Product Type

  • Barium based
  • Iodinated
  • Micro-bubble
  • Gadolinium based

By Application

  • Neurological disorder
  • Cardiovascular disorder
  • Cancer
  • Gastrointestinal disorder
  • Musculoskeletal disorder
  • Nephrological disorder
  • Others

On the basis of Geography

North America

  • The U.S.
  • Canada
  • Mexico

Europe

  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global MRI Contrast Agents Market, (2022 – 2030) (USD Billion)
    • 2.2 Global MRI Contrast Agents Market : snapshot
  • Chapter 3. Global MRI Contrast Agents Market – Industry Analysis
    • 3.1 MRI Contrast Agents Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Patients Suffering With Chronic Diseases
      • 3.2.2 Patients Suffering With Chronic Diseases
      • 3.2.3 Reimbursement Facilities
      • 3.2.4 Patients Suffering With Chronic Diseases
      • 3.2.5 Reimbursement Facilities
      • 3.2.6 Patients Suffering With Pathological
    • 3.3 Market Restraints
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Modality
      • 3.7.2 Market attractiveness analysis By Product Type
      • 3.7.3 Market attractiveness analysis By Application
  • Chapter 4. Global MRI Contrast Agents Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global MRI Contrast Agents Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global MRI Contrast Agents Market – Modality Analysis
    • 5.1 Global MRI Contrast Agents Market overview: By Modality
      • 5.1.1 Global MRI Contrast Agents Market share, By Modality, 2021 and 2030
    • 5.2 X-Ray
      • 5.2.1 Global MRI Contrast Agents Market by X-Ray, 2022 – 2030 (USD Billion)
    • 5.3 CT Scan
      • 5.3.1 Global MRI Contrast Agents Market by CT Scan, 2022 – 2030 (USD Billion)
    • 5.4 Ultrasound
      • 5.4.1 Global MRI Contrast Agents Market by Ultrasound, 2022 – 2030 (USD Billion)
    • 5.5 MRI Scan
      • 5.5.1 Global MRI Contrast Agents Market by MRI Scan, 2022 – 2030 (USD Billion)
  • Chapter 6. Global MRI Contrast Agents Market – Product Type Analysis
    • 6.1 Global MRI Contrast Agents Market overview: By Product Type
      • 6.1.1 Global MRI Contrast Agents Market share, By Product Type, 2021 and 2030
    • 6.2 Barium Based
      • 6.2.1 Global MRI Contrast Agents Market by Barium Based, 2022 – 2030 (USD Billion)
    • 6.3 Iodinated
      • 6.3.1 Global MRI Contrast Agents Market by Iodinated, 2022 – 2030 (USD Billion)
    • 6.4 Micro-Bubble
      • 6.4.1 Global MRI Contrast Agents Market by Micro-Bubble, 2022 – 2030 (USD Billion)
    • 6.5 Gadolinium Based
      • 6.5.1 Global MRI Contrast Agents Market by Gadolinium Based, 2022 – 2030 (USD Billion)
  • Chapter 7. Global MRI Contrast Agents Market – Application Analysis
    • 7.1 Global MRI Contrast Agents Market overview: By Application
      • 7.1.1 Global MRI Contrast Agents Market share, By Application, 2021 and 2030
    • 7.2 Neurological Disorder
      • 7.2.1 Global MRI Contrast Agents Market by Neurological Disorder, 2022 – 2030 (USD Billion)
    • 7.3 Cardiovascular Disorder
      • 7.3.1 Global MRI Contrast Agents Market by Cardiovascular Disorder, 2022 – 2030 (USD Billion)
    • 7.4 Cancer
      • 7.4.1 Global MRI Contrast Agents Market by Cancer, 2022 – 2030 (USD Billion)
    • 7.5 Gastrointestinal Disorder
      • 7.5.1 Global MRI Contrast Agents Market by Gastrointestinal Disorder, 2022 – 2030 (USD Billion)
    • 7.6 Musculoskeletal Disorder
      • 7.6.1 Global MRI Contrast Agents Market by Musculoskeletal Disorder, 2022 – 2030 (USD Billion)
    • 7.7 Nephrological Disorder
      • 7.7.1 Global MRI Contrast Agents Market by Nephrological Disorder, 2022 – 2030 (USD Billion)
  • Chapter 8. MRI Contrast Agents Market – Regional Analysis
    • 8.1 Global MRI Contrast Agents Market Regional Overview
    • 8.2 Global MRI Contrast Agents Market Share, by Region, 2021 & 2030 (USD Billion)
    • 8.3. North America
      • 8.3.1 North America MRI Contrast Agents Market, 2022 – 2030 (USD Billion)
        • 8.3.1.1 North America MRI Contrast Agents Market, by Country, 2022 – 2030 (USD Billion)
    • 8.4 North America MRI Contrast Agents Market, by Modality, 2022 – 2030
      • 8.4.1 North America MRI Contrast Agents Market, by Modality, 2022 – 2030 (USD Billion)
    • 8.5 North America MRI Contrast Agents Market, by Product Type, 2022 – 2030
      • 8.5.1 North America MRI Contrast Agents Market, by Product Type, 2022 – 2030 (USD Billion)
    • 8.6 North America MRI Contrast Agents Market, by Application, 2022 – 2030
      • 8.6.1 North America MRI Contrast Agents Market, by Application, 2022 – 2030 (USD Billion)
    • 8.7. Europe
      • 8.7.1 Europe MRI Contrast Agents Market, 2022 – 2030 (USD Billion)
        • 8.7.1.1 Europe MRI Contrast Agents Market, by Country, 2022 – 2030 (USD Billion)
    • 8.8 Europe MRI Contrast Agents Market, by Modality, 2022 – 2030
      • 8.8.1 Europe MRI Contrast Agents Market, by Modality, 2022 – 2030 (USD Billion)
    • 8.9 Europe MRI Contrast Agents Market, by Product Type, 2022 – 2030
      • 8.9.1 Europe MRI Contrast Agents Market, by Product Type, 2022 – 2030 (USD Billion)
    • 8.10 Europe MRI Contrast Agents Market, by Application, 2022 – 2030
      • 8.10.1 Europe MRI Contrast Agents Market, by Application, 2022 – 2030 (USD Billion)
    • 8.11. Asia Pacific
      • 8.11.1 Asia Pacific MRI Contrast Agents Market, 2022 – 2030 (USD Billion)
        • 8.11.1.1 Asia Pacific MRI Contrast Agents Market, by Country, 2022 – 2030 (USD Billion)
    • 8.12 Asia Pacific MRI Contrast Agents Market, by Modality, 2022 – 2030
      • 8.12.1 Asia Pacific MRI Contrast Agents Market, by Modality, 2022 – 2030 (USD Billion)
    • 8.13 Asia Pacific MRI Contrast Agents Market, by Product Type, 2022 – 2030
      • 8.13.1 Asia Pacific MRI Contrast Agents Market, by Product Type, 2022 – 2030 (USD Billion)
    • 8.14 Asia Pacific MRI Contrast Agents Market, by Application, 2022 – 2030
      • 8.14.1 Asia Pacific MRI Contrast Agents Market, by Application, 2022 – 2030 (USD Billion)
    • 8.15. Latin America
      • 8.15.1 Latin America MRI Contrast Agents Market, 2022 – 2030 (USD Billion)
        • 8.15.1.1 Latin America MRI Contrast Agents Market, by Country, 2022 – 2030 (USD Billion)
    • 8.16 Latin America MRI Contrast Agents Market, by Modality, 2022 – 2030
      • 8.16.1 Latin America MRI Contrast Agents Market, by Modality, 2022 – 2030 (USD Billion)
    • 8.17 Latin America MRI Contrast Agents Market, by Product Type, 2022 – 2030
      • 8.17.1 Latin America MRI Contrast Agents Market, by Product Type, 2022 – 2030 (USD Billion)
    • 8.18 Latin America MRI Contrast Agents Market, by Application, 2022 – 2030
      • 8.18.1 Latin America MRI Contrast Agents Market, by Application, 2022 – 2030 (USD Billion)
    • 8.19. The Middle-East and Africa
      • 8.19.1 The Middle-East and Africa MRI Contrast Agents Market, 2022 – 2030 (USD Billion)
        • 8.19.1.1 The Middle-East and Africa MRI Contrast Agents Market, by Country, 2022 – 2030 (USD Billion)
    • 8.20 The Middle-East and Africa MRI Contrast Agents Market, by Modality, 2022 – 2030
      • 8.20.1 The Middle-East and Africa MRI Contrast Agents Market, by Modality, 2022 – 2030 (USD Billion)
    • 8.21 The Middle-East and Africa MRI Contrast Agents Market, by Product Type, 2022 – 2030
      • 8.21.1 The Middle-East and Africa MRI Contrast Agents Market, by Product Type, 2022 – 2030 (USD Billion)
    • 8.22 The Middle-East and Africa MRI Contrast Agents Market, by Application, 2022 – 2030
      • 8.22.1 The Middle-East and Africa MRI Contrast Agents Market, by Application, 2022 – 2030 (USD Billion)
  • Chapter 9. Company Profiles
    • 9.1 GE Healthcare
      • 9.1.1 Overview
      • 9.1.2 Financials
      • 9.1.3 Product Portfolio
      • 9.1.4 Business Strategy
      • 9.1.5 Recent Developments
    • 9.2 Bracco Imaging SPA
      • 9.2.1 Overview
      • 9.2.2 Financials
      • 9.2.3 Product Portfolio
      • 9.2.4 Business Strategy
      • 9.2.5 Recent Developments
    • 9.3 Bayer AG
      • 9.3.1 Overview
      • 9.3.2 Financials
      • 9.3.3 Product Portfolio
      • 9.3.4 Business Strategy
      • 9.3.5 Recent Developments
    • 9.4 Guerbet
      • 9.4.1 Overview
      • 9.4.2 Financials
      • 9.4.3 Product Portfolio
      • 9.4.4 Business Strategy
      • 9.4.5 Recent Developments
    • 9.5 Lantheus Medical Imaging
      • 9.5.1 Overview
      • 9.5.2 Financials
      • 9.5.3 Product Portfolio
      • 9.5.4 Business Strategy
      • 9.5.5 Recent Developments
    • 9.6 Unijules Life Sciences
      • 9.6.1 Overview
      • 9.6.2 Financials
      • 9.6.3 Product Portfolio
      • 9.6.4 Business Strategy
      • 9.6.5 Recent Developments
    • 9.7 J.B. Chemicals and Pharmaceuticals Ltd.
      • 9.7.1 Overview
      • 9.7.2 Financials
      • 9.7.3 Product Portfolio
      • 9.7.4 Business Strategy
      • 9.7.5 Recent Developments
    • 9.8 SANOCHEMIA Pharmazeutika GmbH
      • 9.8.1 Overview
      • 9.8.2 Financials
      • 9.8.3 Product Portfolio
      • 9.8.4 Business Strategy
      • 9.8.5 Recent Developments
    • 9.9 Taejoon Pharm
      • 9.9.1 Overview
      • 9.9.2 Financials
      • 9.9.3 Product Portfolio
      • 9.9.4 Business Strategy
      • 9.9.5 Recent Developments
    • 9.10 Jodas Expoim
      • 9.10.1 Overview
      • 9.10.2 Financials
      • 9.10.3 Product Portfolio
      • 9.10.4 Business Strategy
      • 9.10.5 Recent Developments
    • 9.11 Nano Therapeutics Pvt. Ltd.
      • 9.11.1 Overview
      • 9.11.2 Financials
      • 9.11.3 Product Portfolio
      • 9.11.4 Business Strategy
      • 9.11.5 Recent Developments
    • 9.12 Kiran X-ray
      • 9.12.1 Overview
      • 9.12.2 Financials
      • 9.12.3 Product Portfolio
      • 9.12.4 Business Strategy
      • 9.12.5 Recent Developments
    • 9.13 iMax Diagnostic Imaging Limited
      • 9.13.1 Overview
      • 9.13.2 Financials
      • 9.13.3 Product Portfolio
      • 9.13.4 Business Strategy
      • 9.13.5 Recent Developments
    • 9.14 YZJ Group
      • 9.14.1 Overview
      • 9.14.2 Financials
      • 9.14.3 Product Portfolio
      • 9.14.4 Business Strategy
      • 9.14.5 Recent Developments
    • 9.15 Livealth Biopharma Pvt. Ltd.
      • 9.15.1 Overview
      • 9.15.2 Financials
      • 9.15.3 Product Portfolio
      • 9.15.4 Business Strategy
      • 9.15.5 Recent Developments
    • 9.16 Trivitron Healthcare Pvt. Ltd.
      • 9.16.1 Overview
      • 9.16.2 Financials
      • 9.16.3 Product Portfolio
      • 9.16.4 Business Strategy
      • 9.16.5 Recent Developments
    • 9.17 Novalek Pharmaceuticals Pvt. Ltd.
      • 9.17.1 Overview
      • 9.17.2 Financials
      • 9.17.3 Product Portfolio
      • 9.17.4 Business Strategy
      • 9.17.5 Recent Developments
    • 9.18 Unispire Biopharma Private Limited
      • 9.18.1 Overview
      • 9.18.2 Financials
      • 9.18.3 Product Portfolio
      • 9.18.4 Business Strategy
      • 9.18.5 Recent Developments
    • 9.19 Acro Lifesciences (I) Pvt. Ltd.
      • 9.19.1 Overview
      • 9.19.2 Financials
      • 9.19.3 Product Portfolio
      • 9.19.4 Business Strategy
      • 9.19.5 Recent Developments
    • 9.20 Congruent Pharmachem Private Limited
      • 9.20.1 Overview
      • 9.20.2 Financials
      • 9.20.3 Product Portfolio
      • 9.20.4 Business Strategy
      • 9.20.5 Recent Developments
    • 9.21 Stanex Drugs & Chemical Pvt. Ltd.
      • 9.21.1 Overview
      • 9.21.2 Financials
      • 9.21.3 Product Portfolio
      • 9.21.4 Business Strategy
      • 9.21.5 Recent Developments
    • 9.22 Beijing Beilu Pharmaceutical Co. Ltd.
      • 9.22.1 Overview
      • 9.22.2 Financials
      • 9.22.3 Product Portfolio
      • 9.22.4 Business Strategy
      • 9.22.5 Recent Developments
    • 9.23 Rege Imaging & Cine Films Private Limited
      • 9.23.1 Overview
      • 9.23.2 Financials
      • 9.23.3 Product Portfolio
      • 9.23.4 Business Strategy
      • 9.23.5 Recent Developments
    • 9.24 K DIAM EXIM
      • 9.24.1 Overview
      • 9.24.2 Financials
      • 9.24.3 Product Portfolio
      • 9.24.4 Business Strategy
      • 9.24.5 Recent Developments
    • 9.25 Subhra Pharma Pvt. Ltd
      • 9.25.1 Overview
      • 9.25.2 Financials
      • 9.25.3 Product Portfolio
      • 9.25.4 Business Strategy
      • 9.25.5 Recent Developments

List Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global MRI Contrast Agents Market, 2022 – 2030 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global MRI Contrast Agents Market attractiveness, By Modality
  • 6. Global MRI Contrast Agents Market attractiveness, By Product Type
  • 7. Global MRI Contrast Agents Market attractiveness, By Application
  • 8. Global MRI Contrast Agents Market share by Modality, 2022 and 2030 (USD Billion)
  • 9. Global MRI Contrast Agents Market by X-Ray, 2022 – 2030 (USD Billion)
  • 10. Global MRI Contrast Agents Market by CT Scan, 2022 – 2030 (USD Billion)
  • 11. Global MRI Contrast Agents Market by Ultrasound, 2022 – 2030 (USD Billion)
  • 12. Global MRI Contrast Agents Market by MRI Scan, 2022 – 2030 (USD Billion)
  • 13. Global MRI Contrast Agents Market share by Product Type, 2022 and 2030 (USD Billion)
  • 14. Global MRI Contrast Agents Market by Barium Based, 2022 – 2030 (USD Billion)
  • 15. Global MRI Contrast Agents Market by Iodinated, 2022 – 2030 (USD Billion)
  • 16. Global MRI Contrast Agents Market by Micro-Bubble, 2022 – 2030 (USD Billion)
  • 17. Global MRI Contrast Agents Market by Gadolinium Based, 2022 – 2030 (USD Billion)
  • 18. Global MRI Contrast Agents Market share by Application, 2022 and 2030 (USD Billion)
  • 19. Global MRI Contrast Agents Market by Neurological Disorder, 2022 – 2030 (USD Billion)
  • 20. Global MRI Contrast Agents Market by Cardiovascular Disorder, 2022 – 2030 (USD Billion)
  • 21. Global MRI Contrast Agents Market by Cancer, 2022 – 2030 (USD Billion)
  • 22. Global MRI Contrast Agents Market by Gastrointestinal Disorder, 2022 – 2030 (USD Billion)
  • 23. Global MRI Contrast Agents Market by Musculoskeletal Disorder, 2022 – 2030 (USD Billion)
  • 24. Global MRI Contrast Agents Market by Nephrological Disorder, 2022 – 2030 (USD Billion)
  • 25. Global MRI Contrast Agents Market share, by Region, 2022 and 2030
  • 26. North America MRI Contrast Agents Market, 2022 – 2030 (USD Billion)
  • 27. Europe MRI Contrast Agents Market, 2022 – 2030 (USD Billion)
  • 28. Asia Pacific MRI Contrast Agents Market, 2022 – 2030 (USD Billion)
  • 29. Latin America MRI Contrast Agents Market, 2022 – 2030 (USD Billion)
  • 30. The Middle-East and Africa MRI Contrast Agents Market, 2022 – 2030 (USD Billion)

List Of Tables

  • 1. Global MRI Contrast Agents Market: Snapshot
  • 2. Drivers of the MRI Contrast Agents Market: impact analysis
  • 3. North America MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 4. North America MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 5. North America MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 6. U.S. MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 7. U.S. MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 8. U.S. MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 9. Canada MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 10. Canada MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 11. Canada MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 12. Europe MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 13. Europe MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 14. Europe MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 15. Germany MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 16. Germany MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 17. Germany MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 18. France MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 19. France MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 20. France MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 21. U.K. MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 22. U.K. MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 23. U.K. MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 24. Italy MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 25. Italy MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 26. Italy MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 27. Spain MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 28. Spain MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 29. Spain MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 30. Rest of Europe MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 31. Rest of Europe MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 32. Rest of Europe MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 33. Asia Pacific MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 34. Asia Pacific MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 35. Asia Pacific MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 36. China MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 37. China MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 38. China MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 39. Japan MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 40. Japan MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 41. Japan MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 42. India MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 43. India MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 44. India MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 45. South Korea MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 46. South Korea MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 47. South Korea MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 48. South-East Asia MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 49. South-East Asia MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 50. South-East Asia MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 51. Rest of Asia Pacific MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 52. Rest of Asia Pacific MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 53. Rest of Asia Pacific MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 54. Latin America MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 55. Latin America MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 56. Latin America MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 57. Brazil MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 58. Brazil MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 59. Brazil MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 60. Mexico MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 61. Mexico MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 62. Mexico MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 63. Rest of Latin America MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 64. Rest of Latin America MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 65. Rest of Latin America MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 66. The Middle-East and Africa MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 67. The Middle-East and Africa MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 68. The Middle-East and Africa MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 69. GCC Countries MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 70. GCC Countries MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 71. GCC Countries MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 72. South Africa MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 73. South Africa MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 74. South Africa MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 75. Rest of Middle-East Africa MRI Contrast Agents Market revenue, By Modality, 2022 – 2030 (USD Billion)
  • 76. Rest of Middle-East Africa MRI Contrast Agents Market revenue, By Product Type, 2022 – 2030 (USD Billion)
  • 77. Rest of Middle-East Africa MRI Contrast Agents Market revenue, By Application, 2022 – 2030 (USD Billion)

Report Methodology

In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:

Preliminary Data Mining

On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.

Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.

Statistical Model

Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.

Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.

Some of the variables taken into account for forecasting are as follows:

• Industry drivers and constraints, as well as their current and projected impact

• The raw material case, as well as supply-versus-price trends

• Current volume and projected volume growth through 2030

We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.

Primary Validation

This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.

Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.

All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:

• Market leaders

• Suppliers of raw materials

• Suppliers of raw materials

• Buyers.

The following are the primary research objectives:

• To ensure the accuracy and acceptability of our data.

• Gaining an understanding of the current market and future projections.

Data Collection Matrix

Perspective Primary research Secondary research
Supply-side
  • Manufacturers
  • Technology distributors and wholesalers
  • Company reports and publications
  • Government publications
  • Independent investigations
  • Economic and demographic data
Demand-side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customers


Market Analysis Matrix

Qualitative analysis Quantitative analysis
  • Industry landscape and trends
  • Market dynamics and key issues
  • Technology landscape
  • Market opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2028
  • Market revenue estimates and forecasts up to 2028, by technology
  • Market revenue estimates and forecasts up to 2028, by application
  • Market revenue estimates and forecasts up to 2028, by type
  • Market revenue estimates and forecasts up to 2028, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Key Players

  • GE Healthcare
  • Bracco Imaging SPA
  • Bayer AG
  • Guerbet
  • Lantheus Medical Imaging
  • Unijules Life Sciences
  • B. Chemicals and Pharmaceuticals Ltd.
  • SANOCHEMIA Pharmazeutika GmbH
  • Taejoon Pharm
  • Jodas Expoim
  • Nano Therapeutics Pvt. Ltd.
  • Kiran X-ray
  • iMax Diagnostic Imaging Limited
  • YZJ Group
  • Livealth Biopharma Pvt. Ltd.
  • Trivitron Healthcare Pvt. Ltd.
  • Novalek Pharmaceuticals Pvt. Ltd.
  • Unispire Biopharma Private Limited
  • Acro Lifesciences (I) Pvt. Ltd.
  • Congruent Pharmachem Private Limited
  • Stanex Drugs & Chemical Pvt. Ltd.
  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Rege Imaging & Cine Films Private Limited
  • K DIAM EXIM
  • Subhra Pharma Pvt. Ltd.

FAQs

The “North America” region will lead the global Contrast Agents MRI market during the forecast period 2022 to 2030.

The key factors driving the market are patients suffering from chronic diseases and advanced health care.

The key players operating in the Contrast Agents MRI market are GE Healthcare, Bracco Imaging SPA, Bayer AG, Guerbet, Lantheus Medical Imaging, Unijules Life Sciences, J.B. Chemicals and Pharmaceuticals Ltd., SANOCHEMIA Pharmazeutika GmbH, Taejoon Pharm, Jodas Expoim, Nano Therapeutics Pvt. Ltd., Kiran X-ray, iMax Diagnostic Imaging Limited, YZJ Group, Livealth Biopharma Pvt. Ltd., Trivitron Healthcare Pvt. Ltd., Novalek Pharmaceuticals Pvt. Ltd., Unispire Biopharma Private Limited, Acro Lifesciences (I) Pvt. Ltd., Congruent Pharmachem Private Limited, Stanex Drugs & Chemical Pvt. Ltd., Beijing Beilu Pharmaceutical Co. Ltd., Rege Imaging & Cine Films Private Limited, K DIAM EXIM, Subhra Pharma Pvt. Ltd.

The global Contrast Agents MRI market is expanding growth with a CAGR of approximately 3.7% during the forecast period (2022 to 2030).

The global Contrast Agents MRI market size was valued at USD 4.9 billion in 2021 and it is projected to reach around USD 5.9 billion by 2030.

PURCHASE OPTIONS

excel
$

3200


pdf excel
$

4200


pdf excel powerbi
$

5200


excel
$

1800

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • Free 25% or 40 hours of customisation.
  • Free post-sale service assistance.
  • 15% discount on your next purchase.
  • Dedicated account Associate .
  • Permission to print the report.
  • Service guarantee available.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • Free 35% or 60 hours of customisation.
  • Free post-sale service assistance.
  • 25% discount on your next purchase.
  • Service guarantee available.
  • Personalised market brief by author.
  • Permission to print the report.
  • PDF, Excel and Power Point.
  • Can be accessible by unlimited users.
  • Free 40% or 80 hours of customisation.
  • Free post-sale service assistance.
  • 30% discount on your next purchase.
  • Permission to print the report.
  • Dedicated account manager.
  • Service guarantee available.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
  • 15% discount on your next purchase.
  • Free 20% or 10 hours of customisation.
View cart

Find it too expensive?
NO WORRIES!